Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4794656
Max Phase: Preclinical
Molecular Formula: C29H36N2O6
Molecular Weight: 508.62
Molecule Type: Unknown
Associated Items:
ID: ALA4794656
Max Phase: Preclinical
Molecular Formula: C29H36N2O6
Molecular Weight: 508.62
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1[C@@H]2C=C[C@H](/C=C/C=C/C(N)=O)[C@H](/C=C/C=C/C(=O)C3=C(O)[C@H](CCC(=O)O)NC3=O)[C@H]2C[C@H]1C
Standard InChI: InChI=1S/C29H36N2O6/c1-3-19-17(2)16-22-20(18(12-13-21(19)22)8-4-7-11-25(30)33)9-5-6-10-24(32)27-28(36)23(31-29(27)37)14-15-26(34)35/h4-13,17-23,36H,3,14-16H2,1-2H3,(H2,30,33)(H,31,37)(H,34,35)/b8-4+,9-5+,10-6+,11-7+/t17-,18+,19-,20+,21+,22-,23+/m1/s1
Standard InChI Key: GSAPWIHNYKLCSK-UJLFHVDHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 508.62 | Molecular Weight (Monoisotopic): 508.2573 | AlogP: 3.54 | #Rotatable Bonds: 11 |
Polar Surface Area: 146.79 | Molecular Species: ACID | HBA: 5 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.54 | CX Basic pKa: | CX LogP: 2.94 | CX LogD: -3.44 |
Aromatic Rings: 0 | Heavy Atoms: 37 | QED Weighted: 0.15 | Np Likeness Score: 1.60 |
1. Jiao YJ,Liu Y,Wang HX,Zhu DY,Shen YM,Li YY. (2020) Expression of the Clifednamide Biosynthetic Pathway in Streptomyces Generates 27,28-seco-Derivatives., 83 (9.0): [PMID:32915576] [10.1021/acs.jnatprod.0c00900] |
Source(1):